The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development
Mirte Post(Medical University of Vienna), Erhard Hofer, Emilio Casanova(Comprehensive Cancer Center Vienna), Wolfgang Eppel(Medical University of Vienna), Ulrike Resch(Medical University of Vienna), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Dagmar Stoiber(Karl Landsteiner University of Health Sciences), Martin Bilban(Medical University of Vienna), Angélica Cuapio(Medical University of Vienna), David M. Davies(Guy's Hospital), Amit Nathwani(Royal Free London NHS Foundation Trust), Markus Osl(Medical University of Vienna), Bernhard Schlechta(Medical University of Vienna), Dorit Lehmann(Medical University of Vienna)
Cited by 49
Related Papers
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
|Immunity|2015|1.4k
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
|New England Journal of Medicine|2014|1.2k
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells
|Circulation Research|2019|312
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Endothelial Cell Activation and Thromboregulation during Xenograft Rejection
|Immunological Reviews|1994|211